Therapy Areas
8 August 2022 - German biotechnology company BioNTech SE (Nasdaq:BNTX) reported on Monday total revenue of EUR3.2bn for the second quarter of 2022, down from EUR5.3bn in the same period a year ago.In the first six months of the year, total revenue gr...
8 August 2022 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company, announced on Sunday that it has dosed its first patient with diabetic macular edema (DME) in the phase one study of IBI324, a potential first-in-class opht...
8 August 2022 - Kodiak Sciences Inc. (Nasdaq: KOD), a US-based biopharmaceutical company, announced on Friday that it has completed enrolment in its GLOW Phase three clinical trial of tarcocimab tedromer (KSI-301), the company's anti-VEGF antibo...
8 August 2022 - United States-based contract research organisation Vial announced on Sunday that it has named Dr Neeraj Agarwal as scientific advisor for the company's Oncology CRO.Dr Agarwal is a genitourinary cancer specialist and has been the...
8 August 2022 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company, announced on Sunday that it has dosed its first patient with diabetic macular edema (DME) in the phase one study of IBI324, a potential first-in-class opht...
8 August 2022 - Transcenta Holding Limited (HKEX: 06628), a China-based, clinical stage biopharmaceutical company, announced on Sunday that it has named Dr Caroline Germa as its executive vice president, Global Medicine Development and chief medical ...
8 August 2022 - China-based Ascletis Pharma Inc. (HKEX: 1672) announced on Sunday that it has completed dosing its first patient in the United States phase one clinical trial of ASC61, an oral PD-L1 small molecule inhibitor prodrug, intended to treat...